Updated July 18, 2026
You have been on CPAP for years. The mask, the hose, the morning dry mouth, the partner complaints, the travel hassle. Every man on CPAP has imagined life without it. With GLP-1-mediated weight loss showing 50 to 60% reductions in apnea severity in clinical trials, the question is no longer hypothetical: can you actually retire the machine?
THE REQUIREMENTS FOR CPAP RETIREMENT
Discontinuing CPAP is a medical decision, not a personal one. The threshold for safely stopping requires:
A follow-up sleep study (polysomnography or home sleep test). This is non-negotiable. Your subjective experience — "I feel better, I'm not snoring" — is not sufficient. Silent apnea events (obstructive events without audible snoring) are common and can persist even after significant weight loss. Only a sleep study can measure your actual AHI.
AHI below 5 events per hour. This is the threshold for "no OSA." An AHI of 5 to 15 is mild OSA (CPAP optional, alternative therapies reasonable). Above 15 is moderate-to-severe (CPAP still recommended). Your sleep physician will make the call based on your post-weight-loss AHI and symptoms.
Sustained weight loss. If your improved AHI depends on maintaining a lower weight, stopping CPAP while still actively losing weight is premature. The assessment should happen at a stable weight — typically 3 to 6 months after reaching your target or after weight loss plateaus.
⚡ The timeline
Most sleep physicians recommend a follow-up sleep study after 6 months of sustained weight loss (not 6 months on the medication, but 6 months at a lower weight). If you've lost 30+ pounds and maintained that loss for 3+ months, ask your sleep doctor about retesting.
WHAT THE DATA SHOWS
The SURMOUNT-OSA trials provide the best available data on GLP-1-mediated CPAP retirement potential:
20% of participants resolved OSA completely (AHI dropped below 5). These patients could theoretically discontinue CPAP.
Another 30 to 40% moved from moderate/severe to mild OSA (AHI 5 to 15). These patients may be candidates for switching from CPAP to less intrusive alternatives — oral appliances, positional therapy, or no device at all, depending on symptoms and physician assessment.
The remaining 40 to 50% improved but still needed CPAP — though often at lower pressure settings, which improves comfort and compliance. Lower pressure means less mask leak, less aerophagia (swallowing air), and less claustrophobic sensation.
The key predictor of who can retire CPAP versus who cannot: starting OSA severity and starting BMI. Men with mild-to-moderate OSA who were moderately obese (BMI 30 to 35) had the best outcomes. Men with severe OSA and BMI above 40 improved significantly but were less likely to achieve complete resolution.
| Starting Profile | Weight Loss Achieved | Typical AHI Change | CPAP Status |
|---|---|---|---|
| Mild OSA + BMI 30–35 | 15–20% | AHI drops below 5 | Can likely retire CPAP |
| Moderate OSA + BMI 30–35 | 15–20% | AHI drops to mild range | May switch to oral appliance |
| Moderate OSA + BMI 35–40 | 15–20% | AHI drops 40–50% | Lower pressure CPAP |
| Severe OSA + BMI 35–40 | 15–20% | AHI drops 30–40% | Still needs CPAP, lower pressure |
| Severe OSA + BMI 40+ | 15–20% | AHI drops 20–30% | CPAP still necessary |
THE TRANSITION PROTOCOL
If your sleep physician clears you to try discontinuing CPAP after weight loss, follow a structured transition rather than just stopping:
Week 1–2: Reduce CPAP pressure by 2 cm H₂O. If you tolerate the lower pressure without returning symptoms, continue.
Week 3–4: Try sleeping without CPAP on weekends only. Monitor how you feel on CPAP-free mornings versus CPAP mornings. If a bed partner can observe you, ask about snoring or breathing pauses.
Week 5–6: Discontinue CPAP if weekend trial was successful. Continue monitoring symptoms (daytime sleepiness, morning headaches, concentration) for 4 weeks.
Month 3: Follow-up sleep study to confirm AHI. This is the objective confirmation. If AHI is below 5, you are done. If it has crept back up, resume CPAP or consider an oral appliance.
⚠️ Weight regain risk
If you discontinue CPAP based on weight-loss-improved AHI, and then regain weight, your OSA may return. GLP-1 medication maintenance is one factor in sustained OSA improvement. If you stop the GLP-1 and regain weight, plan to retest your sleep and potentially resume CPAP.
MadeMed (Tirz) — Inj $189/mo · Oral $229/mo
Injectable tirzepatide $189/mo or oral $229/mo. L-Carnitine boost included.
Tirzepatide injectable $189/mo. The medication in the SURMOUNT-OSA trials.
Paid link · Compounded medications are not FDA-approved and are prepared by state-licensed pharmacies.
Compounded semaglutide and tirzepatide with low intro pricing. FSA/HSA...
Injectable and lozenge semaglutide with 120-day/5% guarantee. Sublingu...
Telehealth-first compounded GLP-1 prescriptions with provider check-in...
RELATED INTEL
GLP-1s and Sperm Quality →The 40% Lean Mass Warning →Protein Timing for Men on GLP-1s →Sources: SURMOUNT-OSA trial outcomes; AASM guidelines on CPAP discontinuation after weight loss; sleep study protocols for OSA reassessment. This article does not constitute medical advice. All CPAP decisions should be made with a board-certified sleep physician.